Skip to main content

The U.S Congress and federal regulatory agencies have been busy this past year and there have been some significant changes impacting pharmacists and pharmacies. This session will provide an overview of new developments on the federal legislative and regulatory front, including an update on Medicare provider status, drug pricing and pharmacist payment reform, telehealth, drug supply chain security, drug importation, compounding, maintaining COVID-19 pharmacist patient care flexibilities, and more. The session will also look at what to expect on the national legislative and regulatory scene in 2022.